Mitochondriopathien im Kindes- und Jugendalter

• Literatur

• 1 Schaefer AM, Taylor RW, Turnbull DM et al. The epidemiology of mitochondrial disorders – past, present and future. Biochim Biophys Acta 2004; 1659: 115-120
• 2 Skladal D, Halliday J, Thorburn DR. Birth prevalence of mitochondrial respiratory chain deficiencies in children. Brain 2003; 196: 1905-1912
• 3 Sperl W, Fleuren L, Freisinger P et al. The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders. J Inherit Metab Dis 2015; 38: 391-403
• 4 Mayr JA, Freisinger P, Schlachter K et al. Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet 2011; 89: 806-812
• 5 Mayr JA, Haack TB, Freisinger P et al. Spectrum of combined respiratory chain defects. J Inherit Metab Dis 2015; 38: 629-640
• 6 Lee IC, El-Hattab AW, Wang J et al. SURF1-associated Leigh syndrome: a case series and novel mutations. Hum Mutat 2012; 33: 1192-200
• 7 Jonckheere AI, Smeitink JA, Rodenburg RJ. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis 2012; 35: 211-225
• 8 Ahting U, Mayr JA, Vanlander AV et al. Clinical, biochemical, and genetic spectrum of seven patients with NFU1 deficiency. Front Genet 2015; 13: 123
• 9 Emmanuele V, López LC, Berardo A et al. Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Arch Neurol 2012; 69: 978-983
• 10 Stehling O, Wilbrecht C, Lill R. Mitochondrial iron-sulfur protein biogenesis and human disease. Biochimie 2014; 100: 61-77
• 11 Mayr JA, Feichtinger RG, Tort F et al. Lipoic acid biosynthesis defects. J Inherit Metab Dis 2014; 37: 553-563
• 12 Haack TB, Makowski C, Yao Y et al. Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome. J Inherit Metab Dis 2012; 35: 943-948
• 13 Area-Gomez E, Schon EA. Mitochondrial genetics and disease. J Child Neurol 2014; 29: 1208-1215
• 14 Koopman WJH, Willems PHGM, Smeitink JAM. Monogenic Mitochondrial Disorders. N Engl J Med 2012; 366: 1132-1141
• 15 Powell CA, Nicholls TJ, Minczuk M. Nuclear-encoded factors involved in post-transcriptional processing and modification of mitochondrial tRNAs in human disease. Front Genet 2015; 6: 79
• 16 Mayr JA. Lipid metabolism in mitochondrial membranes. J Inherit Metab Dis 2015; 38: 137-144
• 17 DiMauro S, Schon EA, Carelli V et al. The clinical maze of mitochondrial neurology. Nat Rev Neurol 2013; 9: 429-444
• 18 Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiat 1951; 14: 216-221
• 19 Baertling F, Rodenburg RJ, Schaper J et al. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry 2014; 85: 257-265
• 20 Copeland WC, Longley MJ. Mitochondrial genome maintenance in health and disease. DNA Repair (Amst) 2014; 19: 190-198
• 21 Uusimaa J, Moilanen JS, Vainionpää L et al. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243 A > G mutation in children. Ann Neurol 2007; 62: 278-287
• 22 Parikh S, Goldstein A, Koenig MK et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial MedicineSociety. Genet Med 2014; 11. Epub ahead of print
• 23 Diagnostik und Therapieansätze bei Mitochondriopathien im Kindes- und Jugendalter, Leitlinien Kinderheilkunde und Jugendmedizin. AWMF-Leitlinien-Register Nr. 027/016 http://www.awmf.org/leitlinien/detail/ll/027-016.html
• 24 Wortmann SB, Duran M, Anikster Y et al. Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature. J Inherit Metab Dis 2013; 36: 923-928
• 25 Scaglia F, Towbin JA, Craigen WJ et al. Clinical spectrum,morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004; 114: 925-931
• 26 Stickler DE, Valenstein E, Neiberger RE et al. Peripheral neuropathy in genetic mitochondrial diseases. Pediatr Neurol 2006; 34: 127-131
• 27 Carroll CJ, Brilhante V, Suomalainen A. Next-generation sequencing for mitochondrial disorders. Br J Pharmacol 2014; 171: 1837-1853
• 28 Haack TB, Haberberger B, Frisch EM et al. Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing. J Med Genet 2012; 49: 277-283
• 29 Klopstock T, Yu-Wai-Man P, Dimitriadis K et al. A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy. Brain 2011; 134: 2677-2686
• 30 Horvath R. Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10). J Inherit Metab Dis 2012; 35: 679-687
• 31 Brown G. Defects of thiamine transport and metabolism. J Inherit Metab Dis 2014; 37: 577-585
• 32 El-Hattab AW, Adesina AM, Jones J et al. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 2015; Jun Epub ahead of print
• 33 Scholl-Bürgi S, Höller A, Pichler K et al. Ketogenic diets in patients with inherited metabolic disorders. J Inherit Metab Dis 2015; 38: 765-773
• 34 Taivassalo T, Gardner JL, Taylor RW et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 2006; 129: 3391-3401
• 35 Tarnopolsky MA. Exercise as a therapeutic strategy for primary mitochondrialcytopathies. J Child Neurol 2014; 29: 1225-1534
• 36 Martinelli D, Catteruccia M, Piemonte F et al. EPI-743 reverses the progression of the pediatric mitochondrial disease--genetically defined Leigh Syndrome. Mol Genet Metab 2012; 107: 383-388
• 37 Tischner C, Wenz T. Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders. Mitochondrion 2015; 24: 32-49
• 38 Viscomi C, Bottani E, Zeviani M. Emerging concepts in the therapy of mitochondrial disease. Biochim Biophys Acta 2015; 1847: 544-557
• 39 Burgstaller JP, Johnston IG, Poulton J. Mitochondrial DNA disease and developmental implications for reproductive strategies. Mol Hum Reprod 2015; 21: 11-22